Pennyes
3 years ago
Under the Radar, grossly neglected and not known stock!, this sleeping Penny is long due for a Run, with the new CEO announcement, the mgmt made a good move!..
CVR Medical Corp. Announces New Chief Executive Officer
Newsfile Corp - Thu Sep 2, 8:01AM CDT
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2021) - CVR Medical Corp. (TSXV: CVM) (OTC Pink: CRRVF) (" CVR Medical " or the " Company " or " we ") a Canadian listed and US based healthcare company in the medical device market is pleased to announce the appointment of Darren Day as Chief Executive Officer (CEO), effective immediately.
Pennyes
4 years ago
Joe,
there is a recent message from CEO, and it is quite interesting because it is the latest update, reveals the future potential in this co.
https://www.barchart.com/story/stocks/quotes/CRRVF/overview/1104673/cvr-medical-corp-message-from-the-chief-executive-officer
CEO and other stakeholders are working on a restructuring, the details are not provided, but it sounds pretty favorable for enhanced share performance!!..
n3m3sis
4 years ago
Details....
Summary
Show definitions
The purpose of this study is to determine the accuracy of a new non-invasive device, the Carotid Stenotic Scan (CSS), to check for stenosis of the internal carotid artery (ICA) as compared to a carotid duplex ultrasound study.
Description
Currently, carotid duplex ultrasound is the primary diagnostic tool for the evaluation for ICA stenosis and must be performed by a trained and certified vascular technologist using advanced duplex imaging equipment and with subsequent interpretation by a trained physician. this test is not considered suitable for screening for disease. It would be of value to develop an accurate, reliable, low-cost, and easily accessible tool to screen for extra-cranial ICA disease in an office based setting. However, such a tool would require novel technology that allows for quick, accurate, reproducible, and safe evaluation.
This study will evaluate a new technology called the Carotid Stenotic Scan (CSS) developed by CVR Medical. The CSS instrument uses sensitive transducers to detect low frequency pressure fluctuations associated with flow disturbances downstream from areas of arterial narrowing.
Subjects will undergo a clinically ordered clinical carotid duplex ultrasound as part of standard of care. Subjects will have a noninvasive CSS assessment either before or after the carotid duplex ultrasound.
Details
Treatment Carotid Stenotic Scan
Clinical Study Identifier NCT04057183
Sponsor Phillip J Bendick
Last Modified on 7 December 2020
n3m3sis
5 years ago
Your wish has been granted :)
"VANCOUVER, BC, June 9, 2020 /CNW/ -
TSX VENTURE COMPANIES
CVR MEDICAL CORP. ("CVM")
BULLETIN TYPE: Reinstated for Trading
BULLETIN DATE: June 9, 2020
TSX Venture Tier 2 Company
Further to the Exchange bulletin dated May 7, 2019; the Exchange has been advised that the Cease Trade Order issued by the British Columbia Securities Commission dated, May 6, 2019, has been revoked.
Further to the news release dated June 8, 2020, effective at the opening, Thursday, June 11, 2020, trading will be Reinstated in the securities of the Company."
CVR Medical re-admitted for trading on TSX